Imeglimin: Current Development and Future Potential in Type 2 Diabetes Chigoziri KonkwoRachel J. Perry Leading Article 28 November 2020 Pages: 185 - 190
Evolving Role of Immunotherapy in Metastatic Castration Refractory Prostate Cancer Nityam RathiTaylor Ryan McFarlandUmang Swami Leading Article Open access 28 December 2020 Pages: 191 - 206
Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects Jerold ChunGavin GiovannoniSamuel F. Hunter Review Article Open access 08 December 2020 Pages: 207 - 231
Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia George G. ZhanelChristina DengJames A. Karlowsky Review Article 28 November 2020 Pages: 233 - 256
Updated Overall Survival in a Randomized Study Comparing Dacomitinib with Gefitinib as First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations Tony S. MokYing ChengYi-Long Wu Original Research Article Open access 17 December 2020 Pages: 257 - 266
Brigatinib: A Review in ALK-Inhibitor Naïve Advanced ALK-Positive NSCLC Sheridan M. Hoy Adis Drug Evaluation 02 February 2021 Pages: 267 - 275
Lumasiran: First Approval Lesley J. ScottSusan J. Keam AdisInsight Report 06 January 2021 Pages: 277 - 282
Lonafarnib: First Approval Sohita Dhillon AdisInsight Report Open access 15 February 2021 Pages: 283 - 289
Correction to: Filgotinib: First Approval Sohita DhillonSusan J. Keam Correction Open access 02 February 2021 Pages: 297 - 297